URGN vs AAPL: Which Stock is Better?
Side-by-side comparison of UroGen Pharma Ltd and Apple Inc in 2026
URGN
UroGen Pharma Ltd
$44.42
AAPL
Apple Inc
$324.17
Key Metrics Comparison
| Metric | URGN | AAPL | Winner |
|---|---|---|---|
| Market Cap | $1.61B | $3.83T | AAPL |
| P/E Ratio | N/A | 34.84 | URGN |
| EPS (TTM) | $N/A | $7.47 | AAPL |
| Revenue Growth | -2.5% | 7.9% | AAPL |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze URGN
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is URGN or AAPL a better investment?
Comparing URGN and AAPL: UroGen Pharma Ltd has a market cap of $1.61B while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between URGN and AAPL?
URGN (UroGen Pharma Ltd) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: URGN or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: URGN or AAPL?
AAPL has higher revenue growth at 7.9% vs -2.5% for URGN.
Which company is more profitable: URGN or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for URGN.
Which is the larger company: URGN or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.83T compared to $1.61B for URGN.
Should I buy URGN or AAPL in 2026?
Both URGN and AAPL have investment merit. URGN trades at $44.42 while AAPL trades at $324.17. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between URGN and AAPL stock?
Key differences: Market Cap ($1.61B vs $3.83T), P/E Ratio (N/A vs 34.8x), Revenue Growth (-2.5% vs 7.9%), Gross Margin (0.0% vs 46.9%).
Should I buy URGN or AAPL in 2026?
The choice between URGN and AAPL depends on your investment goals. AAPL shows higher revenue growth (7.9%). AAPL has better margins (46.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between URGN and AAPL?
URGN (UroGen Pharma Ltd) has a market cap of $1.61B, while AAPL (Apple Inc) has a market cap of $3.83T. AAPL is the larger company by market value.